RSV Roundtable

Last year’s historic RSV season left many wondering if this was going to become a recurring trend. Physicians weigh in on what they are seeing at their institutions in terms of infection rates.

In the second installment of RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.

In the third installment of RSV Roundtable, our panel discusses the impact nirsevimab has had this RSV season.

In the fourth installment of RSV Roundtable, our panel explains the challenges in protecting the senior population against RSV.

In the final installment of our RSV Roundtable video series, our panel breaks down the importance of discussing new immunizations with patients now, and how crucial they will be in future RSV seasons.

In a recent panel, clinicians discussed rising cases of respiratory syncytial virus (RSV), vaccination challenges, and the urgent need for public awareness and intervention strategies in the 2023 to 2024 season.